Monitoring Cerebral Perfusion Changes after Revascularization in Patients with Moyamoya Disease by Using Arterial Spin-labeling MR Imaging.

Purpose To determine whether arterial spin-labeling (ASL) magnetic resonance (MR) imaging could be used to identify changes in cerebral blood flow (CBF), collateral blood flow, and anastomosis site patency after revascularization in patients with moyamoya disease. Materials and Methods This retrospective study was conducted in 145 patients with moyamoya disease who underwent middle cerebral artery (MCA)-superficial temporal artery anastomosis. Preoperative, early postoperative, and late postoperative ASL and digital subtraction angiography images were analyzed. In the MCA territory, absolute CBF (hereafter, CBFMCA) and normalized CBF values adjusted to nonanastomosis side (hereafter, nCBFMCA) and to cerebellum (hereafter, nCBFCbll) were calculated. Collateral grading in the MCA territory was assessed according to Alberta Stroke Program Early CT Score methodology, and anastomosis site patency were also assessed. Changes in CBF were compared by using one-way analysis of variance with Bonferroni correction for multiple comparisons. Intermodality agreement was determined by κ statistics. Results Significant increases in CBFMCA, nCBFMCA, and nCBFCbll were found after revascularization (preoperative and postoperative values of CBFMCA, 35.2 mL/100 g per minute ± 7.8 [mean ± standard deviation] and 51.5 mL/100 g per minute ± 12.0; nCBFMCA, 0.73 mL/100 g per minute ± 0.14 and 1.01 mL/100 g per minute ± 0.18; nCBFCbll, 0.74 mL/100 g per minute ± 0.12 and 1.12 mL/100 g per minute ± 0.16; all P < .001). Agreements for collateral grading and anastomosis patency between ASL MR imaging and digital subtraction angiography were moderate to good, with weighted κ values of 0.77 (95% confidence interval: 0.73, 0.81) and 0.57 (95% confidence interval: 0.37, 0.76), respectively. Conclusion ASL MR imaging can be used to identify perfusion changes in patients with moyamoya disease after revascularization as a noninvasive monitoring tool.

[1]  S. Mugikura,et al.  Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease. , 2009, Surgical neurology.

[2]  Danny J. J. Wang,et al.  Multi-delay arterial spin labeling perfusion MRI in moyamoya disease–comparison with CT perfusion imaging , 2014, European Radiology.

[3]  Greg Zaharchuk,et al.  Monitoring Cerebrovascular Reactivity through the Use of Arterial Spin Labeling in Patients with Moyamoya Disease. , 2016, Radiology.

[4]  John A. Detre,et al.  Clinical neuroimaging using arterial spin-labeled perfusion magnetic resonance imaging , 2007, Neurotherapeutics.

[5]  K. Houkin,et al.  Arterial spin-labeling magnetic resonance imaging after revascularization of moyamoya disease. , 2013, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[6]  Josien P W Pluim,et al.  Arterial Spin Labeling Perfusion MRI at Multiple Delay Times: A Correlative Study with H215O Positron Emission Tomography in Patients with Symptomatic Carotid Artery Occlusion , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[7]  T. Noguchi,et al.  Arterial spin-labeling MR imaging in moyamoya disease compared with SPECT imaging. , 2011, European journal of radiology.

[8]  Hye Rim Cho,et al.  Tumor blood flow from arterial spin labeling perfusion MRI: A key parameter in distinguishing high‐grade gliomas from primary cerebral lymphomas, and in predicting genetic biomarkers in high‐grade gliomas , 2013, Journal of magnetic resonance imaging : JMRI.

[9]  J. Pfeuffer,et al.  Clinical assessment of cerebral hemodynamics in Moyamoya disease via multiple inversion time arterial spin labeling and dynamic susceptibility contrast-magnetic resonance imaging: A comparative study. , 2017, Journal of neuroradiology. Journal de neuroradiologie.

[10]  Donald S. Williams,et al.  Perfusion imaging , 1992, Magnetic resonance in medicine.

[11]  Zhao Yang,et al.  Weighted kappa statistic for clustered matched-pair ordinal data , 2015, Comput. Stat. Data Anal..

[12]  R. O'Gorman,et al.  Arterial spin labelling MRI for assessment of cerebral perfusion in children with moyamoya disease: comparison with dynamic susceptibility contrast MRI , 2013, Neuroradiology.

[13]  K. Chang,et al.  Childhood moyamoya disease: quantitative evaluation of perfusion MR imaging--correlation with clinical outcome after revascularization surgery. , 2009, Radiology.